177 related articles for article (PubMed ID: 7598728)
1. Enhancement of damage-specific DNA binding of XPA by interaction with the ERCC1 DNA repair protein.
Nagai A; Saijo M; Kuraoka I; Matsuda T; Kodo N; Nakatsu Y; Mimaki T; Mino M; Biggerstaff M; Wood RD
Biochem Biophys Res Commun; 1995 Jun; 211(3):960-6. PubMed ID: 7598728
[TBL] [Abstract][Full Text] [Related]
2. Sequential binding of DNA repair proteins RPA and ERCC1 to XPA in vitro.
Saijo M; Kuraoka I; Masutani C; Hanaoka F; Tanaka K
Nucleic Acids Res; 1996 Dec; 24(23):4719-24. PubMed ID: 8972858
[TBL] [Abstract][Full Text] [Related]
3. Mutations in XPA that prevent association with ERCC1 are defective in nucleotide excision repair.
Li L; Peterson CA; Lu X; Legerski RJ
Mol Cell Biol; 1995 Apr; 15(4):1993-8. PubMed ID: 7891694
[TBL] [Abstract][Full Text] [Related]
4. Specific association between the human DNA repair proteins XPA and ERCC1.
Li L; Elledge SJ; Peterson CA; Bales ES; Legerski RJ
Proc Natl Acad Sci U S A; 1994 May; 91(11):5012-6. PubMed ID: 8197174
[TBL] [Abstract][Full Text] [Related]
5. Cell cycle checkpoint abrogator UCN-01 inhibits DNA repair: association with attenuation of the interaction of XPA and ERCC1 nucleotide excision repair proteins.
Jiang H; Yang LY
Cancer Res; 1999 Sep; 59(18):4529-34. PubMed ID: 10493501
[TBL] [Abstract][Full Text] [Related]
6. New design of nucleotide excision repair (NER) inhibitors for combination cancer therapy.
Gentile F; Tuszynski JA; Barakat KH
J Mol Graph Model; 2016 Apr; 65():71-82. PubMed ID: 26939044
[TBL] [Abstract][Full Text] [Related]
7. The XPA-binding domain of ERCC1 is required for nucleotide excision repair but not other DNA repair pathways.
Orelli B; McClendon TB; Tsodikov OV; Ellenberger T; Niedernhofer LJ; Schärer OD
J Biol Chem; 2010 Feb; 285(6):3705-3712. PubMed ID: 19940136
[TBL] [Abstract][Full Text] [Related]
8. Biochemical analysis of the damage recognition process in nucleotide excision repair.
You JS; Wang M; Lee SH
J Biol Chem; 2003 Feb; 278(9):7476-85. PubMed ID: 12486030
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of nucleotide excision repair by anti-XPA monoclonal antibodies which interfere with binding to RPA, ERCC1, and TFIIH.
Saijo M; Matsuda T; Kuraoka I; Tanaka K
Biochem Biophys Res Commun; 2004 Sep; 321(4):815-22. PubMed ID: 15358100
[TBL] [Abstract][Full Text] [Related]
10. DNA repair gets physical: mapping an XPA-binding site on ERCC1.
Croteau DL; Peng Y; Van Houten B
DNA Repair (Amst); 2008 May; 7(5):819-26. PubMed ID: 18343204
[TBL] [Abstract][Full Text] [Related]
11. Formation of a ternary complex by human XPA, ERCC1, and ERCC4(XPF) excision repair proteins.
Park CH; Sancar A
Proc Natl Acad Sci U S A; 1994 May; 91(11):5017-21. PubMed ID: 8197175
[TBL] [Abstract][Full Text] [Related]
12. Identification of a damaged-DNA binding domain of the XPA protein.
Kuraoka I; Morita EH; Saijo M; Matsuda T; Morikawa K; Shirakawa M; Tanaka K
Mutat Res; 1996 Jan; 362(1):87-95. PubMed ID: 8538652
[TBL] [Abstract][Full Text] [Related]
13. Functional and physical interactions between ERCC1 and MSH2 complexes for resistance to cis-diamminedichloroplatinum(II) in mammalian cells.
Lan L; Hayashi T; Rabeya RM; Nakajima S; Kanno Si; Takao M; Matsunaga T; Yoshino M; Ichikawa M; Riele Ht; Tsuchiya S; Tanaka K; Yasui A
DNA Repair (Amst); 2004 Feb; 3(2):135-43. PubMed ID: 14706347
[TBL] [Abstract][Full Text] [Related]
14. Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein-Protein Interaction.
Obermann R; Yemane B; Jarvis C; Franco FM; Kyriukha Y; Nolan W; Gohara B; Krezel AM; Wildman SA; Janetka JW
ChemMedChem; 2024 Apr; 19(8):e202300648. PubMed ID: 38300970
[TBL] [Abstract][Full Text] [Related]
15. Conformational determinants for the recruitment of ERCC1 by XPA in the nucleotide excision repair (NER) Pathway: structure and dynamics of the XPA binding motif.
Fadda E
Biophys J; 2013 Jun; 104(11):2503-11. PubMed ID: 23746523
[TBL] [Abstract][Full Text] [Related]
16. TGF beta promotes repair of bulky DNA damage through increased ERCC1/XPF and ERCC1/XPA interaction.
Zheng H; Jarvis IWH; Bottai M; Dreij K; Stenius U
Carcinogenesis; 2019 Jun; 40(4):580-591. PubMed ID: 30418489
[TBL] [Abstract][Full Text] [Related]
17. Structural basis for the recruitment of ERCC1-XPF to nucleotide excision repair complexes by XPA.
Tsodikov OV; Ivanov D; Orelli B; Staresincic L; Shoshani I; Oberman R; Schärer OD; Wagner G; Ellenberger T
EMBO J; 2007 Nov; 26(22):4768-76. PubMed ID: 17948053
[TBL] [Abstract][Full Text] [Related]
18. Domains in the XPA protein important in its role as a processivity factor.
Bartels CL; Lambert MW
Biochem Biophys Res Commun; 2007 Apr; 356(1):219-25. PubMed ID: 17349973
[TBL] [Abstract][Full Text] [Related]
19. Xeroderma pigmentosum complementation group A protein acts as a processivity factor.
Lambert MW; Yang L
Biochem Biophys Res Commun; 2000 May; 271(3):782-7. PubMed ID: 10814539
[TBL] [Abstract][Full Text] [Related]
20. A truncated human xeroderma pigmentosum complementation group A protein expressed from an adenovirus sensitizes human tumor cells to ultraviolet light and cisplatin.
Rosenberg E; Taher MM; Kuemmerle NB; Farnsworth J; Valerie K
Cancer Res; 2001 Jan; 61(2):764-70. PubMed ID: 11212280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
